Bumrungrad Hospital Public Company Limited (BUGDF) Stock
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited (BUGDF) is a leading healthcare provider that operates a network of medical facilities in Thailand and globally. Its core offering is a comprehensive medical center equipped with advanced diagnostic, therapeutic, and intensive care capabilities. The company also boasts an extensive array of approximately 56 specialized outpatient clinics and centers, covering a broad spectrum of medical disciplines. These include, but are not limited to, allergy, cardiology, behavioral health, oncology, dental, diabetes, emergency services, eye care, fertility, digestive disease, women's health, men's health, orthopedics, physical therapy, plastic surgery, and sleep medicine. Beyond direct patient care, Bumrungrad engages in various related activities. These encompass managing real estate holdings, conducting clinical research, distributing pharmaceutical and medical goods through dedicated stores, operating a training and development center for healthcare professionals, and providing patient referral services. With its substantial infrastructure, the company maintains 580 hospital beds across its facilities. Founded in 1980, Bumrungrad Hospital Public Company Limited is headquartered in Bangkok, Thailand.
Bumrungrad Hospital Public Company Limited is headquartered in TH.
Bumrungrad Hospital Public Company Limited (BUGDF) stock trades at $4.75 with a market capitalization of $3.78B. The stock is valued at a price-to-earnings (P/E) ratio of 19.70, price-to-book of 4.61, price-to-sales of 5.90. Over the past 52 weeks the stock has ranged between $3.95 and $6.31, and currently trades 24.7% below its 52-week high. It pays a dividend yielding 11.58%.
On profitability, Bumrungrad Hospital Public Company Limited generates a return on equity (ROE) of 25.10% — well above the market average, a sign of a high-quality business, return on capital employed of 25.78%, an operating margin of 34.93%, a net profit margin of 29.96%.
Official website: www.bumrungrad.com